STZ
52
-6
YUM
43
-6
ADM
28
3
LEN
50
-2
PLD
45
-5
ACN
47
-5
PBI
56
-2
MO
60
-2
GE
61
-3
BDX
56
10
KMI
69
-2
PGR
59
-3
DOV
65
-4
BMY
55
-8
CVX
43
-3
GT
56
-3
MTCH
20
-8
KSS
39
-7
GRMN
67
-4
PEP
39
-9
STZ
52
-6
YUM
43
-6
ADM
28
3
LEN
50
-2
PLD
45
-5
ACN
47
-5
PBI
56
-2
MO
60
-2
GE
61
-3
BDX
56
10
KMI
69
-2
PGR
59
-3
DOV
65
-4
BMY
55
-8
CVX
43
-3
GT
56
-3
MTCH
20
-8
KSS
39
-7
GRMN
67
-4
PEP
39
-9
Financhill
Back

HCA Healthcare Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

HCA
HCA Healthcare

Last Price:
342.98
Seasonality Move:
11.67%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
48
HCA Healthcare (HCA) is a Sell

Is HCA Healthcare a Buy, Sell or Hold?

  • The current HCA Healthcare [HCA] share price is $342.96. The Score for HCA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • HCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HCA Stock Price Chart

What is HCA Healthcare's stock price today?

  • The HCA Healthcare share price today is $342.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HCA is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.69 Sell
Relative Strength Index (14 RSI): 32.22 Sell
Chaikin Money Flow: 970321 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (348.96 - 398) Sell
Bollinger Bands (100): (339.99 - 398.09) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 350.66 Sell
20-day SMA: 366.03 Sell
50-day SMA: 384.74 Sell
200-day SMA: 345.3 Sell
8-day EMA: 351.13 Sell
20-day EMA: 362.91 Sell
50-day EMA: 373.35 Sell
200-day EMA: 346.33 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

HCA Healthcare Earnings Growth & HCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.79 per share, and an increase next year of $2.68 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

HCA Healthcare Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):